Home/Filings/4/0001209191-11-034655
4//SEC Filing

Schloesser A Eric 4

Accession 0001209191-11-034655

CIK 0001317872other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 7:50 PM ET

Size

14.2 KB

Accession

0001209191-11-034655

Insider Transaction Report

Form 4
Period: 2011-06-10
Schloesser A Eric
VP, Operations & Bus. Dev't.
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2011-06-1027,0350 total
    Exercise: $6.75Exp: 2012-12-07Common Stock (27,035 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2011-06-1081,7650 total
    Exercise: $6.75Exp: 2012-12-07Common Stock (81,765 underlying)
  • Disposition to Issuer

    Common Stock

    2011-06-10284,6860 total
Footnotes (3)
  • [F1]Disposed of pursuant to the Agreement and Plan of Merger dated as of March 6, 2011 (the "Merger Agreement") among Accuray Incorporated ("Accuray"), Jaguar Acquisition, Inc. and TomoTherapy Incorporated ("TomoTherapy"), in exchange for a combination of $896,760.90 in cash and 46,916 shares of Accuray common stock based on $3.15 per share and 0.1648 shares of Accuray Common Stock for each TomoTherapy share held.
  • [F2]These options vested over a three-year period, with 48,290 option shares vesting on 12/7/2008, 21,089 option shares vesting on 12/7/2009 and 12,386 option shares vesting on 12/7/2010. These stock options were cancelled and exchanged for 50,269 new stock options of Accuray with the same vesting terms, based on a conversion ratio of 0.6148, which is (A)(i) $3.15 divided by (ii) $7.00, the volume weighted average of the daily closing price of Accuray for the five (5) consecutive trading days preceding and including June 9, 2011, plus (B) 0.1648 pursuant to the Merger Agreement, at a new exercise price of $10.98, based on the previous exercise price divided by the same conversion ratio.
  • [F3]These options vested over a three-year period, with 6,110 option shares vesting on 12/7/2008, 6,111 option shares vesting on 12/7/2009 and 14,814 option shares vesting on 12/7/2010. These stock options were cancelled and exchanged for 16,621 new stock options of Accuray with the same vesting terms, based on a conversion ratio of 0.6148, which is (A)(i) $3.15 divided by (ii) $7.00, the volume weighted average of the daily closing price of Accuray for the five (5) consecutive trading days preceding and including June 9, 2011, plus (B) 0.1648 pursuant to the Merger Agreement, at a new exercise price of $10.98, based on the previous exercise price divided by the same conversion ratio.

Issuer

TomoTherapy Inc

CIK 0001317872

Entity typeother

Related Parties

1
  • filerCIK 0001394801

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:50 PM ET
Size
14.2 KB